Adequan® Multi-Dose I.M.: Targeted Arthritis Treatment for Equines

Adequan multi dose (intramuscular) is a specialized medication designed to manage and treat degenerative joint disease (DJD), commonly known as arthritis, in horses. It is one of the few disease-modifying osteoarthritis drugs (DMOADs) approved for veterinary use. Specifically formulated to address the underlying causes of arthritis. Rather than just masking the symptoms. By targeting the source of joint inflammation and cartilage degradation. Adequan® helps to slow the progression of arthritis, reduce pain, and improve mobility in equine patients.

How Adequan Multi Dose Works

Adequan® contains polysulfated glycosaminoglycan (PSGAG), a compound that is structurally similar to the components of joint cartilage. When administered intramuscularly, Adequan®:

1. Inhibits Cartilage Breakdown: Adequan® helps to prevent the enzymes responsible for cartilage degradation, slowing the progression of arthritis.
2. Stimulates Cartilage Repair: By promoting the production of synovial fluid and enhancing the repair of damaged cartilage. Adequan® aids in maintaining joint health.
3. Reduces Inflammation: The anti-inflammatory properties of Adequan® help decrease joint inflammation. Which is a primary cause of pain in arthritic horses.
4. Improves Joint Mobility: By addressing the root causes of arthritis, Adequan® helps restore joint function and mobility. Allowing horses to move more comfortably.

Key Benefits :

• Targeted Arthritis Treatment: Unlike many pain relievers that only mask the symptoms. Adequan® targets the underlying issues of arthritis, providing a more comprehensive treatment approach.
• Reduces Pain and Inflammation: Adequan® effectively reduces pain and inflammation associated with arthritis. Helping horses regain their mobility and quality of life.
• Promotes Joint Health: By supporting the repair of damaged cartilage and improving the quality of synovial fluid. Adequan® helps maintain healthier joints over time.
• Convenient Multi-Dose Format: The multi-dose formulation allows for multiple treatments from a single vial, making it more convenient and cost-effective for horse owners and veterinarians.

Usage Instructions

• Administration: Adequan® Multi-Dose I.M. is administer intramuscularly, typically by a veterinarian or under veterinary guidance.
• Dosage: The standard dosing regimen is 500 mg (5 mL) administer every four days for a total of seven injections over 28 days. However, the specific dosage and treatment plan should be determined by a veterinarian based on the individual needs of the horse.
• Treatment Duration: Depending on the severity of the arthritis and the horse’s response to treatment, the veterinarian may recommend additional treatment cycles or maintenance doses.

Precautions

• Veterinary Supervision: Adequan® should only be use under the supervision of a qualified veterinarian to ensure proper administration and monitoring of the horse’s response to treatment.
• Monitor for Adverse Reactions: While generally safe, some horses may experience mild side effects, such as injection site reactions or gastrointestinal upset. Monitoring is important, especially during the initial treatment period.
• Not for Use in Pregnant or Lactating Mares: Adequan® has not been evaluated for safety in pregnant or lactating mares, so its use should be avoided unless deem necessary by a veterinarian.

Conclusion

Adequan multi dose offers a targeted and effective treatment option for managing arthritis in horses. By addressing the root causes of joint degeneration and providing relief from pain and inflammation, Adequan® helps equine patients maintain their mobility and quality of life. For horse owners and veterinarians looking for a long-term solution to equine arthritis. Adequan® is a trust and proven choice. Consult with your veterinarian to determine if Adequan® is right for your horse and to establish an appropriate treatment plan.